• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. The present invention relates to a pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. Said composition is effective and safe for the treatment of inflammation and/or eye pain associated with various diseases or pathological conditions affecting the eye area. In particular, the ophthalmic composition of the invention is indicated, for example, for the treatment of pain and/or inflammation after eye surgery. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2540151A1
    申请号:ES201300963
    申请日:2013-10-11
    公开日:2015-07-08
    发明作者:Fernando Martínez-Alzamora；José Miguel RIZO MARTÍNEZ；Antonia Gómez Calvo；Nuria Sanz Menéndez；Ángel Muñoz Ruiz
    申请人:Farmalider SA；
    IPC主号:
    专利说明:

    image 1
    image2
    image3
    image4
    image5
    image6
    image7
    image8
    image9
    image10
    image11
    image12
    image13
    image14
    image15
    image16
    image17
    image18
    image19
    image20
    image21
    image22
    权利要求:
    Claims (1)
    [1]
    image 1
    image2
    image3
    image4
    类似技术:
    公开号 | 公开日 | 专利标题
    UA119659C2|2019-07-25|Pd-1 antibody, antigen-binding fragment thereof, and medical application thereof
    ES2540151A1|2015-07-08|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use |
    BR112016009889A2|2017-12-05|gip-glp-1 double agonist compounds and methods
    CL2017002527A1|2018-03-23|Use of formyl 2 peptide receptor agonists to treat inflammatory eye diseases. |.
    BR112015020804A2|2017-07-18|phototherapeutic device, method and use
    EA201800064A1|2018-09-28|1,1,1-TRIFTOR-3-HYDROXYPROPAN-2-IL CARBAMATE DERIVATIVES AND 1,1,1-TRIFTOR-4-HYDROXYBUTAN-2-IL CARBAMATE DERIVATIVES AS MIGL INHIBITORS
    CY1121203T1|2020-05-29|THERAPEUTIC USES OF EMPAGLIFLOSINE
    CL2015003690A1|2016-10-28|Use of pridopidine or a salt thereof to prepare a medication useful in the treatment of huntington's disease.
    DOP2016000109A|2016-08-31|SOLID FORMS OF ACID {[5- | -3-HYDROXIPIRIDIN-2-CARBON] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME.
    BR112013031794A2|2016-12-20|oxytomodulin derivatives and pharmaceutical composition for the treatment of obesity comprising the same
    EA201590654A1|2015-12-30|COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE
    BR112016006564A2|2017-09-12|desmoglein 2 | binding proteins and uses thereof
    UY35276A|2014-08-29|New compounds that inhibit the activity of Lp-PLA2
    BR112015004875A2|2017-11-21|antibody formulations and their uses
    WO2016057658A8|2016-06-09|Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
    BR112018006866A2|2018-10-16|ppar agonist compounds, pharmaceutical compositions and methods of use thereof
    EA201691656A2|2017-03-31|THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
    GT201600084A|2017-07-12| PIRIDOPIRAZOLOPIRIMIDINONAS AND INDAZOLOPIRIMIDINONAS AND ITS USE
    BR112017021583A2|2018-07-03|Methods for treating inflammatory disorders
    CL2015003460A1|2016-07-08|Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for the treatment of an ophthalmic disease
    BR112015017381A2|2017-07-11|topical eye analgesic agents
    BR112019002355A2|2019-07-16|compositions and methods for stroke prevention in pediatric patients with sickle cell anemia
    CL2016000019A1|2016-11-04|Compounds derived from deuterated dihydroxyphenyl or a salt thereof; pharmaceutical composition that comprises them and their use for the treatment of neurotransmitter-mediated disorders such as hypotension, sleep disorders, Alzheimer's disease and depression.
    EA201690574A1|2016-09-30|APPLICATION OF PIDOTIMODE IN THE TREATMENT OF DISEASES RELATED TO INFLAMMATION
    BR112015007095A8|2019-08-20|dihydro-6-azafenalene derivatives for the treatment of snc, oncological diseases and related disorders, pharmaceutical composition comprising them and use of said derivatives
    同族专利:
    公开号 | 公开日
    CY1120642T1|2019-12-11|
    ES2540151B1|2016-02-29|
    EP2862565A1|2015-04-22|
    DK2862565T3|2018-08-13|
    RU2014140885A3|2018-06-14|
    US20150105468A1|2015-04-16|
    ES2685023T3|2018-10-05|
    HRP20181282T1|2018-10-05|
    MX2014012158A|2015-05-27|
    PT2862565T|2018-10-16|
    RU2694369C2|2019-07-12|
    BR102014025307A2|2015-09-29|
    US10292953B2|2019-05-21|
    AR097997A1|2016-04-27|
    EP2862565B1|2018-05-23|
    RU2014140885A|2016-04-27|
    MX355770B|2018-04-30|
    HUE040093T2|2019-02-28|
    PL2862565T3|2018-10-31|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    ES2356762A1|2009-09-04|2011-04-13|Farmalider S.A.|Pharmaceutical composition comprising ibuprofen, tramadol and a basic amino acid, preparation method thereof and use of same|
    CN102058581A|2010-11-30|2011-05-18|广东宏盈科技有限公司|Non-steroid anti-inflammatory medicine for external use for ophthalmology|
    WO2013124498A1|2012-02-22|2013-08-29|Farmauder, S.A.|Pharmaceutical composition of ibuprofen and tramadol for injection|
    WO2013150277A1|2012-04-05|2013-10-10|Anant Sharma|Ophthalmic therapy|ES2604816A1|2015-09-09|2017-03-09|Farmalider, S.A.|Pharmaceutical composition of tramadol for ophthalmic use |FR3124M|1961-02-02|Boots Pure Drug Co Ltd|
    US3652589A|1967-07-27|1972-03-28|Gruenenthal Chemie|1--2-aminomethyl cyclohexanols|
    GB1497044A|1974-03-07|1978-01-05|Prodotti Antibiotici Spa|Salts of phenyl-alkanoic acids|
    AU661723B2|1991-10-30|1995-08-03|Mcneilab, Inc.|Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug|
    US20040224010A1|2002-11-15|2004-11-11|Optime Therapeutics, Inc.|Ophthalmic liposome compositions and uses thereof|
    MY135852A|2003-04-21|2008-07-31|Euro Celtique Sa|Pharmaceutical products|
    CN1513442A|2003-06-26|2004-07-21|昆明市延安医院|Prepn. and use of mixture of arginine-burfenum|
    ES2462541T3|2005-06-09|2014-05-23|Meda Ab|Method and composition for the treatment of inflammatory disorders|
    ES2651444T3|2006-10-20|2018-01-26|Johnson & Johnson Consumer Inc.|Combination of acetaminophen with ibuprofen for pain treatment|
    CA2685395A1|2007-04-30|2008-11-06|Adolor Corporation|Compositions of -e-10-oh-nt and methods for their synthesis and use|
    ES2836808T3|2011-04-05|2021-06-28|Optosolve Res & Development Ltd|Ophthalmic treatments|ITUB20153104A1|2015-08-13|2017-02-13|Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm|COMPOSITION AND USE OF COLLIRIO BASED ON INOSITOLO TO IMPROVE THE VISUAL PATIENT ACCOMMODATION|
    RU2624901C2|2015-10-05|2017-07-07|Елизавета Геннадьевна Полунина|Agent for application anaesthesia with antiseptic, optical-keratoprotective properties and method for use thereof in ophthalmology|
    AR102172A1|2015-10-05|2017-02-08|Química Luar S R L|A BACTERICIDE AND VIRUCIDE PHARMACEUTICAL COMPOSITION|
    JP2019534872A|2016-09-30|2019-12-05|マティ セラピューティクス，インク．|Ophthalmic drug sustained-release preparation and use thereof|
    法律状态:
    2016-02-29| FG2A| Definitive protection|Ref document number: 2540151 Country of ref document: ES Kind code of ref document: B1 Effective date: 20160229 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES201300963A|ES2540151B1|2013-10-11|2013-10-11|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use|ES201300963A| ES2540151B1|2013-10-11|2013-10-11|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use|
    MX2014012158A| MX355770B|2013-10-11|2014-10-08|Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use.|
    ES14380031.6T| ES2685023T3|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use|
    PL14380031T| PL2862565T3|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use|
    HUE14380031A| HUE040093T2|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use|
    PT14380031T| PT2862565T|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use|
    EP14380031.6A| EP2862565B1|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmological use|
    RU2014140885A| RU2694369C2|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic application|
    US14/511,321| US10292953B2|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use|
    DK14380031.6T| DK2862565T3|2013-10-11|2014-10-10|Pharmaceutical composition of ibuprofen and tramadol for ophthalmic use|
    ARP140103790A| AR097997A1|2013-10-11|2014-10-10|PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC USE|
    BR102014025307-6A| BR102014025307B1|2013-10-11|2014-10-10|PHARMACEUTICAL COMPOSITION OF IBUPROFEN AND TRAMADOL FOR OPHTHALMIC USE|
    HRP20181282TT| HRP20181282T1|2013-10-11|2018-08-03|Pharmaceuitacal composition of ibuprofen and tramadol for ophthalmological use|
    CY181100867T| CY1120642T1|2013-10-11|2018-08-17|PHARMACEUTICAL COMPOSITION OF IBUPROFEMEN AND TRAMADOL FOR OPHTHALMOLOGICAL USE|
    [返回顶部]